2p3b: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /> <applet load="2p3b" size="450" color="white" frame="true" align="right" spinBox="true" caption="2p3b, resolution 2.100Å" /> '''Crystal Structure ...
 
No edit summary
Line 1: Line 1:
[[Image:2p3b.gif|left|200px]]<br />
[[Image:2p3b.gif|left|200px]]<br /><applet load="2p3b" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2p3b" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2p3b, resolution 2.100&Aring;" />
caption="2p3b, resolution 2.100&Aring;" />
'''Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor'''<br />
'''Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor'''<br />
Line 8: Line 7:


==About this Structure==
==About this Structure==
2P3B is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] with 3TL as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2P3B OCA].  
2P3B is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1] with <scene name='pdbligand=3TL:'>3TL</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Active as [http://en.wikipedia.org/wiki/HIV-1_retropepsin HIV-1 retropepsin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.23.16 3.4.23.16] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2P3B OCA].  


==Reference==
==Reference==
Line 26: Line 25:
[[Category: wild type subtype b hiv protease]]
[[Category: wild type subtype b hiv protease]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov  8 14:55:53 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jan 23 15:05:11 2008''

Revision as of 16:05, 23 January 2008

File:2p3b.gif


2p3b, resolution 2.100Å

Drag the structure with the mouse to rotate

Crystal Structure of the subtype B wild type HIV protease complexed with TL-3 inhibitor

OverviewOverview

Although a majority of HIV-1 infections in Brazil are caused by the, subtype B virus (also prevalent in the United States and Western Europe), viral subtypes F and C are also found very frequently. Genomic differences, between the subtypes give rise to sequence variations in the encoded, proteins, including the HIV-1 protease. The current anti-HIV drugs have, been developed primarily against subtype B and the effects arising from, the combination of drug-resistance mutations with the naturally existing, polymorphisms in non-B HIV-1 subtypes are only beginning to be elucidated., To gain more insights into the structure and function of different, variants of HIV proteases, we have determined a 2.1 A structure of the, native subtype F HIV-1 protease (PR) in complex with the protease, inhibitor TL-3. We have also solved crystal structures of two multi-drug, resistant mutant HIV PRs in complex with TL-3, from subtype B (Bmut), carrying the primary mutations V82A and L90M, and from subtype F (Fmut), carrying the primary mutation V82A plus the secondary mutation M36I, at, 1.75 A and 2.8 A resolution, respectively. The proteases Bmut, Fwt and, Fmut exhibit sevenfold, threefold, and 54-fold resistance to TL-3, respectively. In addition, the structure of subtype B wild type HIV-PR in, complex with TL-3 has been redetermined in space group P6(1), consistent, with the other three structures. Our results show that the primary, mutation V82A causes the known effect of collapsing the S1/S1' pockets, that ultimately lead to the reduced inhibitory effect of TL-3. Our results, further indicate that two naturally occurring polymorphic substitutions in, subtype F and other non-B HIV proteases, M36I and L89M, may lead to early, development of drug resistance in patients infected with non-B HIV, subtypes.

About this StructureAbout this Structure

2P3B is a Protein complex structure of sequences from Human immunodeficiency virus 1 with as ligand. Active as HIV-1 retropepsin, with EC number 3.4.23.16 Full crystallographic information is available from OCA.

ReferenceReference

Structural Characterization of B and non-B Subtypes of HIV-Protease: Insights into the Natural Susceptibility to Drug Resistance Development., Sanches M, Krauchenco S, Martins NH, Gustchina A, Wlodawer A, Polikarpov I, J Mol Biol. 2007 Jun 15;369(4):1029-40. Epub 2007 Mar 24. PMID:17467738

Page seeded by OCA on Wed Jan 23 15:05:11 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA